92
90
Growth Score 92 in past quarter
16 pts
Heat Score 90 in past quarter
57 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
349939
Belupo develops and manufactures generic prescription and OTC medicines across cardiovascular, anti-infective, CNS, and dermatology areas.
About the Company
Belupo develops and manufactures prescription and over-the-counter medicines with a focus on generic therapies. Product lines address cardiovascular disease, infectious disease, central nervous system disorders, dermatology, and other primary care areas. Capabilities cover formulation development, GMP manufacturing, analytical testing, and
packaging for solid oral and topical dosage forms. Research and development advances new generic products and supports bioequivalence and lifecycle improvements. Distribution supplies pharmacies, hospitals, and wholesalers under branded generics while maintaining pharmacovigilance and regulatory compliance.